PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
10.15%
Net income growth 1.25-1.5x AVGO's 8.35%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
2.49%
Some D&A expansion while AVGO is negative at -1.89%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-112.50%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
13.11%
SBC growth while AVGO is negative at -4.28%. John Neff would see competitor possibly controlling share issuance more tightly.
67.77%
Less working capital growth vs. AVGO's 236.52%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
95.88%
AR growth well above AVGO's 142.91%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-38.46%
Both reduce yoy inventory, with AVGO at -201.96%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-124.64%
Both negative yoy AP, with AVGO at -231.82%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
52.00%
Lower 'other working capital' growth vs. AVGO's 1050.00%. David Dodd would see fewer unexpected short-term demands on cash.
-2750.00%
Both negative yoy, with AVGO at -4.71%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
14.65%
Operating cash flow growth similar to AVGO's 14.65%. Walter Schloss would see parallel improvements or market conditions in cash generation.
-25.32%
Both yoy lines negative, with AVGO at -10.53%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
29.83%
Purchases growth of 29.83% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
22.75%
Liquidation growth of 22.75% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-1878.95%
We reduce yoy other investing while AVGO is 200.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
111.45%
We have mild expansions while AVGO is negative at -3.28%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment 1.25-1.5x AVGO's 83.34%. Bruce Berkowitz would see an edge in lowering interest burdens unless competitor invests in profitable expansions.
-72.45%
Negative yoy issuance while AVGO is 102.86%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-46.00%
Both yoy lines negative, with AVGO at -104.89%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.